| Issue Date | Title | Author(s) |
| 2021 | 3D organotypic cell structures for drug development and Microorganism-Host interaction research | Zubareva, E. V.; Nadezhdin, S. V.; Belyaeva, V. S.; Burda, Yu. E.; Avtina, T. V.; Gudyrev, O. S. |
| 2016 | Development and validation of methods of quantitative determination of the new antidiabetic drug in the blood plasma of rats by high performance liquid chromatography with mass spectrometric detection | Buzov, A. A.; Kulikov, A. L.; Avtina, T. V.; Pokrovskii, M. V.; Osipova, O. A. |
| 2015 | Ion channel TRPA₁ is a promising therapeutic target for treatment of pain | Beskhmelnitsyna, E. A.; Korokin, M. V; Avtina, T. V.; Martynova, O. V.; Varavin, I. I.; Tishin, A. N. |
| 2016 | Molecular screening of prospective candidates for TRPA₁ ion channel selective antagonists | Kravchenko, D. V.; Beskhmelnitsyna, E. A.; Korokin, M. V.; Avtina, T. V.; Sernov, L. N. |
| 2017 | Nanoparticles as agents for targeted delivery in the treatment of vascular pathologies | Sernov, L. N.; Bogachev, I. A.; Avtina, T. V. |
| 2017 | Oswald Schmiedeberg - the "father" of experimental pharmacology | Pokrovskii, M. V.; Avtina, T. V.; Zakharova, E. V. |
| 2016 | Pharmacokinetic studies derived indole SS-68 with antiarrhythmic and antianginal properties | Galenko-Yaroshevsky, P. A.; Kulikov, A. L.; Vinakov, D. V.; Avtina, T. V.; Suzdalev, K. F. |
| 2016 | Pharmacokinetic studies of new antiparkinsonian drug Rapitalam | Avdeeva, N. V.; Kulikov, A. L.; Pokrovskii, M. V.; Avtina, T. V. |
| 2023 | Pulmonary hypertension: modern methods of treatment and ways of their long-term development | Zagrebelnaya, A. V.; Korokina, L. V.; Malorodova, T. N.; Shcheblykina, O. V.; Avtina, T. V.; Bolgov, A. A. |
| 2018 | Search and evaluation of pharmacodynamic and pharmacokinetic parameters of selective blocker of TRPA₁ ion channels from the group of substituted pyrazinopyrimidinones | Beskhmelnitsyna, E. A.; Dolzhikova, I. N.; Avtina, T. V.; Kulikov, A. L.; Rozhnova, D. V.; Yakushev, V. I.; Martynov, M. A. |
